Composition and methods for the diagnosis of immune related diseases involving the PRO52254 polypeptide
US-RE46534-E · Sep 5, 2017 · US
Anti-TIGIT anibodies, anti-PVRIG antibodies and combinations thereof
US10213505B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10213505-B2 |
| Application number | US-201815937784-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 27, 2018 |
| Priority date | Aug 17, 2016 |
| Publication date | Feb 26, 2019 |
| Grant date | Feb 26, 2019 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Anti-PVRIG and anti-TIGIT antibodies are provided.
First claim
Opening claim text (preview).
What is claimed: 1. A composition comprising an anti-PVRIG antibody, wherein said antibody comprises: i) a heavy chain comprising SEQ ID NO:9, and ii) a light chain comprising SEQ ID NO:14. 2. A composition comprising an anti-PVRIG antibody, wherein said antibody comprises: i) a heavy chain comprising SEQ ID NO:19, and ii) a light chain comprising SEQ ID NO:24.
Assignees
Inventors
Classifications
CH2 domain · CPC title
cytotoxic response · CPC title
against CD28 or CD152 · CPC title
Antagonist effect on antigen, e.g. neutralization or inhibition of binding · CPC title
Comprising a combination of two or more separate antibodies · CPC title
Patent family
Related publications grouped by family.
External sources
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US10213505B2 cover?
- Anti-PVRIG and anti-TIGIT antibodies are provided.
- Who is the assignee on this patent?
- Compugen Ltd
- What technology area does this patent fall under?
- Primary CPC classification A61K39/39558. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue Feb 26 2019 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 10 related publications on this page (citations in our corpus or others sharing the same primary CPC).